Scribd Logo
Upload

Welcome to Scribd!

  • 10 Largest US Patent Drug Losses

    Uploaded by

    Prasad Mahadevan
    8 views3 pages

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    8 views3 pages

    10 Largest US Patent Drug Losses

    Uploaded by

    Prasad Mahadevan

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 3

    10 Largest U.S. Patent Losses : 1) Drug: Lipitor Company: Pfizer 2010 U.S. sales: $5.329 billion/$10.

    133 billion global Impact: 18.35% of U.S. sales Exclusivity expires: November 2011
    Like Follow post 37 minutes ago near Mumbai

    Varun Doshi 2) Drug: Singulair Company: Merck 2010 U.S. sales: $3.224 billion/$4.987 billion global Impact: 15.96% of U.S. sales Exclusivity expires: August 2012 36 minutes ago Like

    Varun Doshi 3) Drug: Diovan Company: Novartis 2010 U.S. sales: $2.520 billion/$6.053 billion global Impact: 15.89% of U.S. sales Exclusivity expires: September 2012 36 minutes ago Like

    Varun Doshi 4) Drug: Provigil Company: Teva Pharmaceutical Industries (via Cephalon buyout) 2010 U.S. sales: $1.059 billion/$1.120 billion global Impact: 10.6% of Teva's U.S. sales, 49.4% of Cephalon's Exclusivity expires: April 2012 36 minutes ago Like

    Varun Doshi 5) Drug: TriCor Company: Abbott Laboratories 2010 U.S. sales: $1.015 billion/$1.582 global (includes TriLipix) Impact: 6.68% of U.S. sales Patent expires: July 2012 35 minutes ago Like

    Varun Doshi 6) Drug: Lexapro Company: Forest Laboratories 2010 U.S. sales: $2.316 billion Impact: 52.63% of U.S. revenue Exclusivity expires: March 2012 33 minutes ago Like

    Varun Doshi 7) Drug: Actos Company: Takeda Pharmaceutical 2010 U.S. sales: $3.35 billion/$4.3 billion global Impact: 51.82% of U.S. revenue Patent expires: August 2012 33 minutes ago Like

    Varun Doshi 8_ Drug: Plavix Company: Bristol-Myers Squibb, in a co-marketing deal with Sanofi 2010 U.S. sales: $6.154 billion, booked by BMS Impact: 48.79% of U.S. revenue Exclusivity expires: May 2012 33 minutes ago Like

    Varun Doshi 9) Drug: Seroquel Company: AstraZeneca 2010 U.S. sales: $3.107 billion/$4.148 billion global

    Impact: 22.63% of U.S. sales Exclusivity expires: March 2012 33 minutes ago Like

    Varun Doshi 10) Drug: Zyprexa Company: Eli Lilly 2010 U.S. sales: $2.495 billion/$5.026 billion global Impact: 19.4% of U.S. sales Exclusivity expires: October 2011 SOURCE: FIERCE PHARMA 32 minutes ago Like
    Write a comment...

    You might also like